Your browser is no longer supported. Please, upgrade your browser.
ADMA Biologics, Inc.
Index- P/E- EPS (ttm)-0.87 Insider Own0.50% Shs Outstand87.70M Perf Week-5.04%
Market Cap212.80M Forward P/E- EPS next Y-0.46 Insider Trans11.80% Shs Float70.91M Perf Month5.12%
Income-66.90M PEG- EPS next Q-0.16 Inst Own54.50% Short Float16.34% Perf Quarter2.73%
Sales40.30M P/S5.28 EPS this Y38.90% Inst Trans-0.02% Short Ratio3.50 Perf Half Y-19.00%
Book/sh0.81 P/B2.79 EPS next Y45.90% ROA-37.20% Target Price- Perf Year-44.88%
Cash/sh0.63 P/C3.56 EPS next 5Y- ROE-98.80% 52W Range1.45 - 4.30 Perf YTD15.90%
Dividend- P/FCF- EPS past 5Y13.30% ROI- 52W High-47.42% Beta1.79
Dividend %- Quick Ratio4.20 Sales past 5Y37.80% Gross Margin-33.70% 52W Low55.86% ATR0.13
Employees313 Current Ratio8.50 Sales Q/Q43.10% Oper. Margin- RSI (14)53.07 Volatility6.33% 5.69%
OptionableYes Debt/Eq1.36 EPS Q/Q0.00% Profit Margin- Rel Volume1.38 Prev Close2.46
ShortableYes LT Debt/Eq1.36 EarningsNov 05 AMC Payout- Avg Volume3.31M Price2.26
Recom1.80 SMA203.96% SMA508.89% SMA200-10.80% Volume4,577,993 Change-8.13%
Jun-04-19Initiated Jefferies Buy $8
Apr-15-19Reiterated H.C. Wainwright Buy $10 → $13
Feb-07-19Resumed H.C. Wainwright Buy $10
Dec-11-17Reiterated Maxim Group Buy $13 → $8
Nov-14-17Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17Upgrade Maxim Group Hold → Buy $13
Aug-01-16Downgrade Maxim Group Buy → Hold
Jul-25-16Reiterated Maxim Group Buy $24 → $14
May-13-15Reiterated Maxim Group Buy $18 → $24
Dec-08-14Initiated Oppenheimer Outperform $20
Dec-01-14Reiterated Maxim Group Buy $16 → $18
Jan-26-21 08:00AM  
Jan-19-21 08:00AM  
Jan-04-21 08:00AM  
Dec-21-20 11:24PM  
Dec-19-20 11:26AM  
Dec-16-20 04:15PM  
Dec-09-20 10:33AM  
Dec-08-20 11:35AM  
Dec-01-20 07:00AM  
Nov-10-20 07:00AM  
Nov-07-20 07:11AM  
Nov-06-20 09:31AM  
Nov-05-20 06:55PM  
Oct-29-20 07:00AM  
Oct-28-20 12:55PM  
Oct-21-20 07:00AM  
Oct-14-20 08:43AM  
Oct-07-20 09:16AM  
Oct-06-20 10:29AM  
Oct-01-20 08:41AM  
Sep-14-20 11:56AM  
Sep-09-20 07:00AM  
Sep-08-20 06:41AM  
Sep-03-20 07:00AM  
Sep-02-20 07:00AM  
Aug-25-20 08:55AM  
Aug-24-20 01:30PM  
Aug-10-20 01:03PM  
Aug-05-20 07:25PM  
Aug-03-20 07:34AM  
Jul-29-20 07:00AM  
Jul-07-20 08:55AM  
Jul-06-20 07:00AM  
Jul-03-20 10:13AM  
Jun-23-20 12:49PM  
Jun-09-20 03:21PM  
Jun-01-20 09:44AM  
May-27-20 07:00AM  
May-21-20 07:00AM  
May-07-20 10:30AM  
May-06-20 08:15PM  
May-01-20 06:13AM  
Apr-29-20 07:00AM  
Apr-03-20 03:48AM  
Mar-17-20 06:12AM  
Mar-12-20 04:05PM  
Mar-05-20 06:59AM  
Mar-03-20 07:00AM  
Feb-24-20 07:00AM  
Feb-13-20 05:07AM  
Feb-11-20 04:20PM  
Feb-07-20 07:32AM  
Feb-06-20 08:41PM  
Jan-09-20 07:00AM  
Jan-07-20 07:00AM  
Dec-23-19 05:36AM  
Dec-17-19 07:08AM  
Dec-14-19 08:04PM  
Nov-13-19 07:08AM  
Nov-08-19 05:33AM  
Nov-06-19 05:02PM  
Nov-04-19 07:08AM  
Oct-28-19 03:05PM  
Oct-22-19 07:48AM  
Oct-21-19 07:48AM  
Oct-17-19 07:29AM  
Oct-09-19 11:08AM  
Oct-07-19 07:08AM  
Oct-03-19 07:08AM  
Sep-23-19 07:08AM  
Sep-09-19 02:54PM  
Aug-22-19 07:48AM  
Aug-08-19 07:51AM  
Jul-08-19 08:22AM  
Jun-27-19 09:30AM  
Jun-18-19 04:35PM  
Jun-06-19 07:25AM  
May-30-19 06:14PM  
May-29-19 07:11AM  
May-24-19 10:30AM  
ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DEMSKI MARTHA JDirectorSep 11Buy2.292,2005,0384,200Sep 14 08:00 AM
Grossman Jerrold BDirectorSep 10Buy2.225,00011,100160,864Sep 11 08:00 AM
Mond JamesEVP, CSO and CMOSep 08Buy2.204,0008,80073,174Sep 10 08:01 AM
Grossman Adam SPresident and CEOSep 08Buy2.244,0008,960176,098Sep 10 08:00 AM
Grossman Jerrold BDirectorAug 21Buy2.565,30013,586155,864Aug 25 08:00 AM
DEMSKI MARTHA JDirectorAug 13Buy2.882,0005,7602,000Aug 14 08:00 AM
Grossman Jerrold BDirectorAug 12Buy2.8910,20029,499150,564Aug 13 08:01 AM
LENZ BRIANEVP, CFOAug 11Buy2.974,00011,86076,142Aug 12 08:02 AM
Grossman Adam SPresident and CEOAug 11Buy2.971,0002,970172,098Aug 12 08:02 AM
Grossman Adam SPresident and CEOAug 10Buy3.065,00015,290171,098Aug 12 08:02 AM
Mond JamesEVP, CSO and CMOAug 10Buy2.887,00020,15069,174Aug 12 08:01 AM
PERCEPTIVE ADVISORS LLC10% OwnerMar 19Buy2.10500,0001,050,00016,584,802Mar 23 08:30 AM
PERCEPTIVE ADVISORS LLC10% OwnerFeb 11Buy3.504,563,70015,972,95016,084,802Feb 11 08:02 AM
Guiheen Lawrence P.DirectorFeb 11Buy3.5020,00070,00070,000Feb 11 10:18 AM
Mond JamesCSO and CMOFeb 11Buy3.504,28514,99822,174Feb 11 10:16 AM
Grossman Jerrold BDirectorFeb 11Buy3.5022,85780,00022,857Feb 11 10:15 AM
Grossman Jerrold BDirectorFeb 11Buy3.5022,85780,000132,864Feb 11 10:15 AM
LENZ BRIANEVP, CFOFeb 11Buy3.507,14224,99732,142Feb 11 10:13 AM
Grossman Adam SPresident and CEOFeb 11Buy3.5057,143200,001878,444Feb 11 10:11 AM
Grossman Adam SPresident and CEOFeb 11Buy3.5028,57199,99966,098Feb 11 10:11 AM